Piper Jaffray Upgrades Alnylam Pharmaceuticals (ALNY) to Overweight

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/21/2026

1. WMT
2. ROST
3. AAP
4. NVDA
5. SPY
6. AVGO
7. SPCX
8. BJ
9. BABA
10. OSIS

August 16, 2011 7:23 AM EDT
Get Alerts ALNY Hot Sheet
Price: $236.22 +3.02%

Rating Summary:
    29 Buy, 12 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Piper Jaffray upgraded Alnylam Pharmaceuticals (NASDAQ: ALNY) from Neutral to Overweight, price target increased from $10 to $12.

For more ratings news on Alnylam Pharmaceuticals click here and for the rating history of Alnylam Pharmaceuticals click here.

Shares of Alnylam Pharmaceuticals closed at $7.34 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Upgrades

Related Entities

Piper Jaffray